BD BIOSCIENCES
United States $ 217,653 $ 205,349 6.0
International 350,180 286,078 22.4
TOTAL $ 567,833 $ 491,427 15.5
TOTAL REVENUES
United States $ 1,574,001 $ 1,474,644 6.7
International 1,878,691 1,602,805 17.2
TOTAL $ 3,452,692 $ 3,077,449 12.2
BECTON DICKINSON AND COMPANY
SUPPLEMENTAL REVENUE INFORMATION
REVENUES BY BUSINESS SEGMENTS AND UNITS
Three Months Ended March 31,
(Unaudited; Amounts in thousands)
United States
2008 2007 % Change
BD MEDICAL
Medical Surgical Systems $ 232,447 $ 230,881 0.7
Diabetes Care 96,883 97,647 (0.8)
Pharmaceutical Systems 52,779 44,370 19.0
Ophthalmic Systems 6,172 5,891 4.8
TOTAL $ 388,281 $ 378,789 2.5
BD DIAGNOSTICS
Preanalytical Systems $ 140,674 $ 131,937 6.6
Diagnostic Systems 140,414 133,863 4.9
TOTAL $ 281,088 $ 265,800 5.8
BD BIOSCIENCES
Cell Analysis (1) $ 78,269 $ 71,719 9.1
Discovery Labware 36,312 37,710 (3.7)
TOTAL $ 114,581 $ 109,429 4.7
TOTAL UNITED STATES $ 783,950 $ 754,018 4.0
(1) Cell Analysis consists of the Immunocytometry Systems and the
Pharmingen units that were previously reported separately.
<
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2008 PR Newswire. All rights reserved |